AMS

Clinical trial pipeline · Data from ClinicalTrials.gov

See which AMS trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 4

NCT07118462

HighCycle Study: Acetazolamide, High Altitude and Plasma Volume

Each year, millions of people living at low altitude (\< 1,000 m) travel to high altitude (≥ 2,500 m) for work, tourism, or sports activities. These individuals…

Kyrgyzstan270 participantsStarted 2024-07-15

Treatment: Acetazolamide, Placebo

All recent trials (59 shown)

Active — Not RecruitingEarly Phase 1

NCT07517068

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

High altitude travel can lead to inflammation in the body and activation of innate immune cells. The investigators' prior research demonstrates that 1 to 3 days…

United States19 participantsStarted 2025-09-17

Treatment: ACETAZOLAMIDE oral capsule, Placebo Arm

Not Yet RecruitingNot Applicable

NCT07148674

Efficacy of Positive Expiratory Pressure on Acute Mountain Sickness

This pilot study aims to evaluate the efficacy of positive expiratory pressure (PEP) therapy at 10 cmH₂O in improving peripheral oxygen saturation (SpO₂) and mi…

Location not specified3 participantsStarted 2025-09-05

Treatment: Positive Expiratory Pressure (10cmH2O) in hypobaric hypoxia

AMS

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HighCycle Study: Acetazolamide, High Altitude and Plasma Volume

All recent trials (59 shown)

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Efficacy of Positive Expiratory Pressure on Acute Mountain Sickness

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

HighCycle Study: Acetazolamide, High Altitude and Plasma Volume

All recent trials (59 shown)

The Role of Acetazolamide in Mitigating Inflammation and Innate Immune Activation at High Altitude

Efficacy of Positive Expiratory Pressure on Acute Mountain Sickness

Pharmacokinetics of Benzo[a]Pyrene: Impact of Diet

Benzo[a]Pyrene Ultralow Dose-Response Study

Ultralow Dose PAH Binary Mixture Study

Safety and Efficacy of T89 in the Prevention and Treatment of Adults With Acute Mountain Sickness (AMS)

Efficacy of Prophylactic Treatment of Oral Prochlorperazine for Acute Mountain Sickness

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of Novel Coronavirus Disease 2019 (COVID-19)

Optimization Strategy for the Prevention of AMS by RIPC Combined With Acetazolamide

Hydrogen-Oxygen Generator With Nebulizer for Adjuvant Treatment of COVID-19 Positive Patients

Hydrogen-Oxygen Generator With Nebulizer for Rehabilitation Treatment of COVID-19

The Impact of the Establishment of a New AMS CPS in a Rural Hospital in Austria

To Evaluate the Safety and Performance of the AMS ActivHeal Silicone Foam and the ActivHeal Silicone Foam Lite Dressing.

Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplant…

Human Mass Balance Study of Pyronaridine

AMS Evaluation Study

A Study To Asses Mass Balance And Absolute Bioavailability Of 14C PF-06826647 In Healthy Male Participants

Comparison of CPAP and Gamow Bag Ventilation to Treat HAPE

Hydrogen-oxygen Gas Mixture Inhalation in Patients With Convalescent Coronavirus Disease 2019 (COVID-19)